Skip Navigation


Hum. Reprod. Advance Access originally published online on November 10, 2005
Human Reproduction 2006 21(2):503-511; doi:10.1093/humrep/dei345
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow All Versions of this Article:
21/2/503    most recent
dei345v2
dei345v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (18)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Mateizel, I.
Right arrow Articles by Van Steirteghem, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mateizel, I.
Right arrow Articles by Van Steirteghem, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Derivation of human embryonic stem cell lines from embryos obtained after IVF and after PGD for monogenic disorders

I. Mateizel1,*, N. De Temmerman1,*, U. Ullmann1,*, G. Cauffman1, K. Sermon1,2,5, H. Van de Velde1,3, M. De Rycke1,2, E. Degreef4, P. Devroey1,3, I. Liebaers1,2 and A. Van Steirteghem1,3

1 Research Centre for Reproduction and Genetics, 2 Centre for Medical Genetics, 3 Centre for Reproductive Medicine and 4 Department of Pathology, University Hospital and Medical School of the Vrije Universiteit Brussel (Dutch-speaking Brussels Free University) Laarbeeklaan 101, 1090 Brussels, Belgium * These authors contributed equally to this work

5 To whom correspondence should be addressed at: University Hospital and Medical School of the Vrije Universiteit Brussel, Research Centre for Reproduction and Genetics, Laarbeeklaan 101, 1090 Brussels, Belgium. E-mail: karen.sermon{at}az.vub.ac.be

BACKGROUND: Human embryonic stem (hES) cells are pluripotent cells usually derived from the inner cell mass (ICM) of blastocysts. Because of their ability to differentiate into all three embryonic germ layers, hES cells represent an important material for studying developmental biology and cell replacement therapy. hES cell lines derived from blastocysts diagnosed as carrying a genetic disorder after PGD represent in vitro disease models. METHODS: ICMs isolated by immunosurgery from human blastocysts donated for research after IVF cycles and after PGD were plated in serum-free medium (except VUB01) on mouse feeder layers. RESULTS: Five hES cell lines were isolated, two from IVF embryos and three from PGD embryos. All lines behave similarly in culture and present a normal karyotype. The lines express all the markers considered characteristic of undifferentiated hES cells and were proven to be pluripotent both in vitro and in vivo (ongoing for VUB05_HD). CONCLUSIONS: We report here on the derivation of two hES cell lines presumed to be genetically normal (VUB01 and VUB02) and three hES cell lines carrying mutations for myotonic dystrophy type 1 (VUB03_DM1), cystic fibrosis (VUB04_CF) and Huntington disease (VUB05_HD).

Key words: cystic fibrosis/disease models/human embryonic stem cells/Huntington disease/myotonic dystrophy


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Mol Hum ReprodHome page
U. Ullmann, C. Gilles, M. De Rycke, H. Van de Velde, K. Sermon, and I. Liebaers
GSK-3-specific inhibitor-supplemented hESC medium prevents the epithelial-mesenchymal transition process and the up-regulation of matrix metalloproteinases in hESCs cultured in feeder-free conditions
Mol. Hum. Reprod., March 1, 2008; 14(3): 169 - 179.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
S. Kuntz, E. Kieffer, L. Bianchetti, N. Lamoureux, G. Fuhrmann, and S. Viville
Tex19, a Mammalian-Specific Protein with a Restricted Expression in Pluripotent Stem Cells and Germ Line
Stem Cells, March 1, 2008; 26(3): 734 - 744.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
T. Turetsky, E. Aizenman, Y. Gil, N. Weinberg, Y. Shufaro, A. Revel, N. Laufer, A. Simon, D. Abeliovich, and B.E. Reubinoff
Laser-assisted derivation of human embryonic stem cell lines from IVF embryos after preimplantation genetic diagnosis
Hum. Reprod., January 1, 2008; 23(1): 46 - 53.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
G. de Wert, I. Liebaers, and H. Van de Velde
The Future (R)evolution of Preimplantation Genetic Diagnosis/Human Leukocyte Antigen Testing: Ethical Reflections
Stem Cells, September 1, 2007; 25(9): 2167 - 2172.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
U. Ullmann, P. In't Veld, C. Gilles, K. Sermon, M. De Rycke, H. Van de Velde, A. Van Steirteghem, and I. Liebaers
Epithelial-mesenchymal transition process in human embryonic stem cells cultured in feeder-free conditions
Mol. Hum. Reprod., January 1, 2007; 13(1): 21 - 32.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
G. Cauffman, I. Liebaers, A. Van Steirteghem, and H. Van de Velde
POU5F1 Isoforms Show Different Expression Patterns in Human Embryonic Stem Cells and Preimplantation Embryos
Stem Cells, December 1, 2006; 24(12): 2685 - 2691.
[Abstract] [Full Text] [PDF]

Home page
 ReproductionHome page
H. Skottman and O. Hovatta
Culture conditions for human embryonic stem cells.
Reproduction, November 1, 2006; 132(5): 691 - 698.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.